Stéphane bancel - activities

Omicron variant: current vaccines likely less effectives, according to Moderna CEO

Shall one fear a major loss in the effectiveness of the current vaccines because of the Omicron variant? Interview by the Financial Times, Moderna CEO Stéphane Bancel expects a “material drop” in the Covid vaccines effectiveness currently given.

Covid: pandemic to end in the second semester of 2022, according to Moderna CEO

Thanks to enough doses to vaccinate “all the inhabitants in the world”, Moderna CEO Stéphane Bancel, considers the Covid-19 pandemic will be over in a year, in the second semester of 2022.

Covid vaccine: Moderna vaccine effective for at least 6 months, the company says

The American company has released results from the second quarter and confirms their Covid vaccine is effective for at least 6 months.

Covid: the “pandemic phase” to come to a close in 2022, according to Moderna French CEO Stéphane Bancel

While the Delta variant is spreading in Europe, many people wonder about the evolution of the coronavirus-related health crisis. In an interview given to Le Point, Moderna French CEO Stéphane Bancel said “the pandemic phase” of Covid-19 “will be over in late 2022”, adding yet “the virus will not disappear from the planet”.

Covid vaccine: a third dose required for people at risk from this summer, according to Moderna

Moderna Therapeutics French CEO Stéphane Bancel has announced this Saturday May 22 to our peers from JDD a third dose of Covid vaccine would be necessary from the end of summer for people at risk to extend immunity and prevent a new epidemic wave caused by variants. He also announced he sought approval in Europe to vaccinate teenagers.

Covid: a 3rd dose of Moderna vaccine to be working against variants, a study found

Is Moderna’s Covid vaccine effective against Brazilian and South African variants after a third dose? This is what the American laboratory found this Wednesday May 5, releasing the preliminary and encouraging results of phase 2 of their clinical trial on the matter.